Your session is about to expire
← Back to Search
Sodium Fluorescein for Neurosurgical Tumors
Study Summary
This trial found that using sodium fluorescein can help during the resection of pediatric neurosurgical tumors.
- Pediatric Neurosurgical Tumors
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is there a way for me to participate in this experiment?
"Eligibility criteria for this study include a minimum age of 31 days and no more than 21 years old, with cancer as the primary condition. The trial plans to accept 120 participants in total."
Has the research community conducted any previous investigations regarding Sodium Fluorescein?
"At this time, there are 7 Sodium Fluorescein trials that have yet to be completed and one of these is in the third Phase. While Ann Arbor, Michigan hosts most of the experiments involving Sodium Fluorescein, a total of 222 sites across the world are conducting such studies."
What goals is this experiment hoping to accomplish?
"During the pre-operative assessment to outpatient follow up period, extending for 6 weeks, researchers will primarily evaluate the percentage of intracranial tumors resected. Secondary objectives include assessing positive predictive value with contingency tables and data from tumour extraction; gauging specificity by correlating fluorescein staining to histopathological diagnosis; and estimating sensitivity through similar correlation techniques."
To what extent is this research project being populated?
"Affirmative, the information found on clinicaltrials.gov affirms that this medical research is being conducted presently. The trial was initiated in August 2021 and lastly updated September 2022; they are searching for 120 individuals from a single site."
What medical purpose is Sodium Fluorescein typically employed for?
"Sodium Fluorescein is frequently used when treating patients with peritoneal dialysis therapy. Additionally, it may be beneficial for those suffering from lymphocyte count measurement issues, as well as pneumocystis jirovecii pneumonia and other forms of the genus pneumocystis."
Does the study protocol accept individuals aged seventy or above?
"This clinical trial is accessible to individuals between 31 days and 21 years of age. Notably, there are 301 trials for paediatric patients and 2209 studies targeting elderly adults."
Are there currently any openings for enrolment in this investigation?
"According to the data accessible on clinicaltrials.gov, this experiment is currently seeking eligible individuals; it was initially posted on August 11th 2021 and revised recently on September 16 2022."
Share this study with friends
Copy Link
Messenger